Tonix Pharmaceuticals Holding Corp

Research Tonix Pharmaceuticals Holding Corp (TNXP) on Bullrun: market cap USD 181.12M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTNXP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 181.12M
• Financial periodFY2025
• RevenueUSD 13.11M
• Revenue growth29.8%
• Net income-USD 124.02M
• Free cash flow-USD 103.21M
• Gross margin49.3%

Valuation Snapshot

latest market cap is USD 181.12M.

About Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States. The company offers TONMYA, a cyclobenzaprine HCl sublingual tablet for the treatment of fibromyalgia. It also markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.

Frequently asked questions

What is Tonix Pharmaceuticals Holding Corp's market cap?

Tonix Pharmaceuticals Holding Corp's market capitalization is USD 181.12M.

What does Tonix Pharmaceuticals Holding Corp do?

Tonix Pharmaceuticals Holding Corp., a fully integrated biopharmaceutical company, develops and commercializes therapies for central nervous system (CNS) disorders, immunology and immuno-oncology, infectious diseases, and rare diseases in the United States.